ClinVar Miner

Submissions for variant NM_058216.3(RAD51C):c.1004_1005delinsAA (p.Cys335Ter)

dbSNP: rs1598535096
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001009663 SCV001169758 likely pathogenic Hereditary cancer-predisposing syndrome 2021-10-29 criteria provided, single submitter clinical testing The c.1004_1005delGCinsAA variant (also known as p.C335*), located in coding exon 8 of the RAD51C gene, results from an in-frame deletion of GC and insertion of AA at nucleotide positions 1004 to 1005. This changes the amino acid from a cysteine to a stop codon within coding exon 8. This alteration occurs at the 3' terminus of theRAD51C gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 42 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.